| Higher prevalence of homologous recombination deficiency in tumors from African Americans versus European Americans S Sinha, KA Mitchell, A Zingone, E Bowman, N Sinha, AA Schäffer, ... Nature Cancer 1 (1), 112-121, 2020 | 39 | 2020 |
| Immune determinants of the association between tumor mutational burden and immunotherapy response across cancer types N Sinha, S Sinha, C Valero, AA Schäffer, K Aldape, K Litchfield, TA Chan, ... Cancer research 82 (11), 2076-2083, 2022 | 22 | 2022 |
| A comprehensive map of alternative polyadenylation in African American and European American lung cancer patients A Zingone, S Sinha, M Ante, C Nguyen, D Daujotyte, ED Bowman, ... Nature Communications 12 (1), 1-12, 2021 | 11 | 2021 |
| Prediction of cancer treatment response from histopathology images through imputed transcriptomics D Hoang, G Dinstag, LC Hermida, DS Ben-Zvi, E Elis, K Caley, S Sammut, ... | 6* | 2022 |
| Using a recently approved tumor mutational burden biomarker to stratify patients for immunotherapy may introduce a sex bias N Sinha, S Sinha, K Cheng, S Madan, A Erez, BM Ryan, AA Schäffer, ... JCO precision oncology 5, 2021 | 4 | 2021 |
| Functional interrogation of twenty type 2 diabetes-associated genes using isogenic human embryonic stem cell-derived β-like cells D Xue, N Narisu, DL Taylor, M Zhang, C Grenko, HJ Taylor, T Yan, X Tang, ... Cell Metabolism 35 (11), 1897-1914. e11, 2023 | 3 | 2023 |
| Deep characterization of cancer drugs mechanism of action by integrating large-scale genetic and drug screens S Sinha, N Sinha, E Ruppin bioRxiv, 2022.10. 17.512424, 2022 | 1 | 2022 |
Sanju SinhaNational Cancer InstituteVerified email at terpmail.umd.edu
